Omada Investment Managers is an AMF-regulated Paris-based SGP licensed in 2024 under GP code GP-20240025 evolved from the 2018 investor-entrepreneur club Omada Conseil founded by Jean-Baptiste Marchand (Amala Partners founder) and Olivier Breittmayer (ex-Exclusive Networks CEO). The legal SGP entity was created 29 November 2023 as a SAS with SIREN 982248890 LEI 969500OZXS3P414SMC62 headquartered at 50 rue de Monceau 75008 Paris. The firm is led by President Nizar Chayeb who previously spent more than a decade at Amundi Private Equity Funds in the fund-of-funds team and at Essling Capital after a 2004-2006 analyst stint at Eurazeo. Omada operates two strategies: co-investments alongside lead PE managers targeting European enterprise values of EUR 50M to EUR 1B and a fund-of-funds programme allocating to European and North American PE funds with sizes from EUR 200M to EUR 4B. Sectors include TMT business services industrials and healthcare. According to the FY2024 ADEME Climate Transparency Hub Article 29 LEC report Omada Investment Managers had EUR 0M deployed at end-2024 reflecting the SGP s recent licensing and early-stage fundraising. The firm announced a marketed vehicle named OTEF USA I focused on US family-controlled mid-market businesses but no AMF AIFM registration has been publicly confirmed for this fund as of mid-2026. Omada is parented or affiliated with Amala Partners the M&A advisory firm founded by Jean-Baptiste Marchand.
Key facts
Recent exits
No exits recorded yet.
Coverage notes
0 funds tracked, 0 portfolio companies (0 active · 0 realized). Verified weekly from public filings and deal announcements.
About Omada Investment Managers
Omada Investment Managers is a European growth equity platform with capital deployed across 1 active fund vehicles and a founding year of 2023, headquartered in Paris. The firm targets profitable mid-cap businesses across TMT, industrials and healthcare, deploying minority and selective majority equity tickets alongside founder and management teams.
Investment thesis
The platform targets profitable European mid-cap companies across TMT, industrials and healthcare, deploying growth equity into minority and selective majority equity positions. Investment focus emphasises buy-and-build strategies, operational scaling and selective international expansion across France and selectively across Europe, with the team's sector specialisation enabling deep partnership with management teams throughout the post-investment value-creation phase.
Recent activity
Realised exits across the current platform vintages remain limited, with the portfolio in active deployment and value-creation phase. The platform tracks 1 dedicated investment vehicle, 5 active portfolio companies and 0 realised exits across the strategy's history. Detailed buyer names and multiple data available on Pro at €29/month.
Similar firms
Other private equity firms tracked on GP Intel.